MoneyWorks4Me

RPG Life Sciences - Quaterly Results

30 Apr 2024 Evaluate
A fair growth of 7.17% in the revenue at Rs. 1269.90 millions was reported in the March 2024 quarter as compared to Rs. 1184.90 millions during year-ago period.Good  Net Profit growth of 27.92% reported above the corresponding previous quarter figure of Rs. 103.50 millions to Rs. 132.40 millioins.Operating profit for the quarter ended March 2024 rose to 223.70 millions as compared to 177.50 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 1269.90 1184.90 7.17 5820.50 5128.10 13.50 5820.50 5128.10 13.50
Other Income 16.50 18.40 -10.33 72.10 48.00 50.21 72.10 48.00 50.21
PBIDT 223.70 177.50 26.03 1353.60 1074.90 25.93 1353.60 1074.90 25.93
Interest 1.40 0.50 180.00 4.50 3.10 45.16 4.50 3.10 45.16
PBDT 222.30 177.00 25.59 1349.10 1071.80 25.87 1349.10 1071.80 25.87
Depreciation 44.90 38.90 15.42 170.70 155.00 10.13 170.70 155.00 10.13
PBT 177.40 138.10 28.46 1178.40 916.80 28.53 1178.40 916.80 28.53
TAX 45.00 34.60 30.06 301.80 240.40 25.54 301.80 240.40 25.54
Deferred Tax -9.50 -2.30 313.04 -23.60 -3.10 661.29 -23.60 -3.10 661.29
PAT 132.40 103.50 27.92 876.60 676.40 29.60 876.60 676.40 29.60
Equity 132.30 132.30 0.00 132.30 132.30 0.00 132.30 132.30 0.00
PBIDTM(%) 17.62 14.98 17.59 23.26 20.96 10.95 23.26 20.96 10.95
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..